Advances in understanding the pathogenesis of primary Sjögren's syndrome
- 16 July 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 9 (9), 544-556
- https://doi.org/10.1038/nrrheum.2013.110
Abstract
Primary Sjögren's syndrome (pSS) is a prototypic autoimmune disorder, management of which has long suffered from a lack of knowledge of the underlying pathophysiological mechanisms; however, over the past decade major advances have been made in understanding the pathogenesis of pSS. The innate immune system has been demonstrated to have an important role at the early stage of the disease, notably through activation of the type I interferon (IFN) system. In addition, mechanisms of B-cell activation in pSS have become clearer, particularly owing to recognition of the involvement of the TNF family cytokine B-cell-activating factor, production of which is highly dependent on expression of type I and type II IFNs. Moreover, key inroads have been made in understanding lymphomagenesis, the most severe complication of pSS. IL-12 production and subsequent T-cell activation, mainly IFN-γ-secreting type 1 T-helper cells, have also been implicated in disease pathogenesis. Furthermore, evidence implicates neuroendocrine system dysfunction in pSS pathogenesis. These pathophysiological advances open new avenues of investigation. Indeed, the increased understanding of pSS pathogenesis has already led to the development of promising novel therapeutic strategies. This article summarizes recent findings regarding the pathogenic mechanisms involved in pSS and their implications.Keywords
This publication has 125 references indexed in Scilit:
- Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseasesProceedings of the National Academy of Sciences of the United States of America, 2012
- Sequencing of TNFAIP3 and association of variants with multiple autoimmune diseasesGenes & Immunity, 2011
- MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndromeArthritis & Rheumatism, 2011
- The chemokine receptor CXCR5 is pivotal for ectopic mucosa-associated lymphoid tissue neogenesis in chronic Helicobacter pylori-induced inflammationJournal of Molecular Medicine, 2010
- Defective feedback regulation of NF-κB underlies Sjögren ’ s syndrome in mice with mutated κB enhancers of the IκBα promoterProceedings of the National Academy of Sciences of the United States of America, 2010
- Expansion of human NK-22 cells with IL-7, IL-2, and IL-1β reveals intrinsic functional plasticityProceedings of the National Academy of Sciences of the United States of America, 2010
- Interleukin‐12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndromeArthritis & Rheumatism, 2009
- Peripheral blood gene expression profiling in Sjögren's syndromeGenes & Immunity, 2009
- Association of an IRF5 gene functional polymorphism with Sjögren's syndromeArthritis & Rheumatism, 2007
- DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002